- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.11. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 October 2024 | 1 | ASX | ||
| 05.11. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 October 2024 | - | ASX | ||
| 04.10. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 30 September 2024 | - | ASX | ||
| 04.10. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 30 September 2024 | - | ASX | ||
| G MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln | |||||
| 30.09. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Annual Report FYE 30 June 2024 | - | ASX | ||
| 05.09. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 August 2024 | - | ASX | ||
| 05.09. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 August 2024 | - | ASX | ||
| 07.08. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 July 2024 | - | ASX | ||
| 06.08. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 July 2024 | - | ASX | ||
| 11.07. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Dividend component details | - | ASX | ||
| 04.07. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 30 June 2024 | - | ASX | ||
| 03.07. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 30 June 2024 | - | ASX | ||
| 01.07. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Dividend Reinvestment Plan Prices | - | ASX | ||
| 28.06. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Final Dividend/Distribution for period ending 30 June 2024 | - | ASX | ||
| 24.06. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Dividend Timetable | - | ASX | ||
| 07.06. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 May 2024 | - | ASX | ||
| 06.06. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 May 2024 | - | ASX |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 9,260 | +8,37 % | If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today | ||
| BICO GROUP | 3,016 | +2,03 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| HIMS & HERS HEALTH | 21,870 | +5,75 % | Starke Konkurrenz befürchtet: Hims & Hers: Katastrophaler Crash nach Allzeithoch! | © Foto: UnsplashDie Anteile der Online-Apotheke Hims & Hers stehen unter Druck, nachdem E-Commerce-Riese Amazon angekündigt hat, einen Telemedizin-Service zu starten.Hinter der Aktie der US-Online-Apotheke... ► Artikel lesen | |
| DEXCOM | 70,62 | -1,08 % | Am Weltdiabetestag hilft Dexcom Menschen mit Diabetes zu entdecken, was in ihnen steckt | San Diego/Mainz (ots) - - Dexcom stellt neue Umfragedaten vor, die zeigen, welchen Einfluss die CGM-Technologie darauf hat, dass Menschen mit Diabetes ihre Träume verfolgen können. - Die Erhebung zeigt... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,063 | +6,06 % | NuGen Medical: Wichtige News und olympische Unterstützung für den InsuJet! | ||
| PLUS THERAPEUTICS | 1,154 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive... ► Artikel lesen | |
| INVITAE | 0,110 | 0,00 % | Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding | ||
| HEALWELL AI | 1,070 | +3,88 % | HEALWELL AI begrüßt Beatrice York, Dr. Marcel Reichart und Reeva Misra in seinem Strategic Advisory Board | - HEALWELL AI kündigt die Gründung
eines Strategic Advisory Board an, der die globalen Wachstumsinitiativen des Unternehmens unterstützen sowie fachkundige Beratung zur Produktentwicklung... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,158 | +2,12 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium | SEATTLE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical stage biopharmaceutical company developing innovative medicines in areas... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care Hydrogel | BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| CYTOSORBENTS | 0,877 | +0,46 % | CytoSorbents; Converge Biotech: CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India | PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,839 | -1,18 % | TPST Stock Plummets to 52-Week Low at $0.85 Amid Market Struggles |
G MEDICAL INNOVATIONS HOLDINGS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu G MEDICAL INNOVATIONS HOLDINGS LTD finden Sie auf Wallstreet Online.
